{"filing":{"accession_number":"0001193125-26-273544","cik":"0001782303","ticker":"BOLD","company_name":"Boundless Bio, Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"bold-20260615.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1782303/000119312526273544/bold-20260615.htm"},"events":[{"id":11485,"run_id":10082,"accession_number":"0001193125-26-273544","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the final results of votes at Boundless Bio's annual stockholder meeting held June 15, 2026, covering two proposals: election of Class II directors (James Christensen and Jennifer Lew) and ratification of KPMG LLP as independent auditor. The tabulated vote counts for each proposal are the core disclosure required under Item 5.07, making this a textbook shareholder vote results filing that is material to investors assessing board composition and audit oversight.","company_name":"Boundless Bio, Inc.","ticker":"BOLD","filing_date":"2026-06-17","form":"8-K","submitted_at":null,"items":[{"id":8082,"accession_number":"0001193125-26-273544","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final results of votes at Boundless Bio's annual stockholder meeting held June 15, 2026, covering two proposals: election of Class II directors (James Christensen and Jennifer Lew) and ratification of KPMG LLP as independent auditor. The tabulated vote counts for each proposal are the core disclosure required under Item 5.07, making this a textbook shareholder vote results filing that is material to investors assessing board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T14:50:11.371714+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8082,"accession_number":"0001193125-26-273544","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final results of votes at Boundless Bio's annual stockholder meeting held June 15, 2026, covering two proposals: election of Class II directors (James Christensen and Jennifer Lew) and ratification of KPMG LLP as independent auditor. The tabulated vote counts for each proposal are the core disclosure required under Item 5.07, making this a textbook shareholder vote results filing that is material to investors assessing board composition and audit oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T14:50:11.371714+00:00","company_name":"Boundless Bio, Inc.","ticker":"BOLD","filing_date":"2026-06-17"}]}